| Literature DB >> 32316934 |
Xiao-Na Li1,2, Ji-Long Zheng3, Xiao-Han Wei1, Bao-Jie Wang1, Jun Yao4.
Abstract
BACKGROUND: Previous studies found that Ser9Gly (rs6280) might be involved in the occurrence of schizophrenia. However, no consist conclusion has yet been achieved. Compared to the case-control study, the family-based study took into account stratification bias. Thus, we conducted a meta-analysis of family-based studies to measure a pooled effect size of the association between Ser9Gly and the risk of schizophrenia.Entities:
Keywords: Dopamine receptor D3; Family study; Meta-analysis; Schizophrenia
Mesh:
Substances:
Year: 2020 PMID: 32316934 PMCID: PMC7171831 DOI: 10.1186/s12881-020-01018-w
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Fig. 1The search flow diagram
Meta-analysis of TDT studies of the association between DRD3 Ser9Gly and schizophrenia
| Author | Year | Location | Ethnicity | Diagnostic criteria | Number of transmissions | Ser9 allele | Expected distribution | OR | 95% CI | Z-value | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | NT | T | NT | ||||||||||
| Macciardi41 | 1994 | Italy | Caucasian | DSM-III-R | 108 | 57 | 51 | 54 | 54 | 1.118 | 0.766–1.630 | 0.577 | 0.564 |
| Rothschild42 | 1996 | USA | Caucasian | DSM-III-R | 71 | 43 | 28 | 35.5 | 35.5 | 1.536 | 0.959–2.459 | 1.786 | 0.074 |
| Malhotra43 | 1998 | USA | Caucasian | DSM-III-R | 149 | 74 | 75 | 74.5 | 74.5 | 0.987 | 0.716–1.360 | −0.082 | 0.935 |
| Kalsi44 | 1998 | British and Iceland | Caucasian | DSM-III-R | 78 | 33 | 45 | 39 | 39 | 0.733 | 0.469–1.146 | −1.361 | 0.173 |
| Williams26 | 1998 | Europe | Caucasian | DSM-III-R | 160 | 84 | 76 | 80 | 80 | 1.105 | 0.811–1.507 | 0.633 | 0.527 |
| Ambrósio45 | 2004 | Portugal | Caucasian | DSM-IV | 74 | 35 | 39 | 37 | 37 | 0.897 | 0.569–1.416 | −0.465 | 0.642 |
| Lu46 | 2005 | China | East Asian | CCMD-III | 162 | 68 | 94 | 81 | 81 | 0.723 | 0.531–0.986 | −2.047 | 0.041 |
| Wang47 | 2006 | China | East Asian | CCMD-III | 42 | 19 | 23 | 21 | 21 | 0.826 | 0.451–1.515 | −0.618 | 0.537 |
| Talkowski48 | 2006 | USA | Caucasian | DSM-IV | 125 | 71 | 54 | 62.5 | 62.5 | 1.315 | 0.924–1.870 | 1.523 | 0.128 |
| Talkowski48 | 2006 | India | Indian | DSM-IV | 130 | 70 | 60 | 65 | 65 | 1.167 | 0.827–1.646 | 0.877 | 0.380 |
| Pawel49 | 2010 | Poland | Caucasian | DSM-IV, ICD-10 | 120 | 57 | 63 | 60 | 60 | 0.905 | 0.632–1.294 | −0.548 | 0.584 |
| Subgroup of East Asian | 204 | 87 | 117 | 102 | 102 | 0.744 | 0.564–0.980 | −2.104 | 0.035 | ||||
| Subgroup of Caucasian | 885 | 454 | 431 | 442.5 | 442.5 | 1.053 | 0.923–1.202 | 0.771 | 0.441 | ||||
| Subgroup of DSM-III-R | 566 | 291 | 275 | 283 | 283 | 1.058 | 0.897–1.248 | 0.673 | 0.501 | ||||
| Subgroup of DSM-IV | 449 | 233 | 216 | 224.5 | 224.5 | 1.079 | 0.897–1.298 | 0.803 | 0.422 | ||||
| Subgroup of CCMD-III | 204 | 87 | 117 | 102 | 102 | 0.744 | 0.564–0.980 | −2.104 | 0.035 | ||||
| Total | 1219 | 611 | 608 | 609.5 | 609.5 | 1.005 | 0.898–1.125 | 0.086 | 0.932 | ||||
Note: T, transmitted (number of times the allele is transmitted from heterozygous parents to the proband); NT, not transmitted
Fig. 2Forest plot of the association between DRD3 Ser9Gly and schizophrenia for TDT studies. a: the statistical significance and Ser9 as a protective factor; b: the statistical significance and Ser9 as a risk factor
Fig. 3Funnel plot of study precision by log odds ratio for TDT studies
Meta-analysis of HRR studies of the association between DRD3 Ser9Gly and schizophrenia
| Author | Year | Location | Ethnicity | Diagnostic criteria | Sample size | Transmitted | Untransmitted | OR | 95% CI | Z-value | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ser9 | Gly9 | Ser9 | Gly9 | ||||||||||
| Prasad47 | 1999 | India | Indians | DSM-IV | 264 | 67 | 65 | 62 | 70 | 1.164 | 0.718–1.886 | 0.615 | 0.538 |
| Kremer48 | 2000 | Palestinian | Arabian | DSM-IV | 516 | 173 | 85 | 172 | 86 | 1.018 | 0.705–1.468 | 0.094 | 0.925 |
| Ambrosio42 | 2004 | Portugal | Caucasian | DSM-IV | 360 | 122 | 58 | 126 | 54 | 0.901 | 0.577–1.409 | −0.455 | 0.649 |
| Lu43 | 2005 | China | East Asian | CCMD-III | 404 | 94 | 108 | 120 | 82 | 0.595 | 0.401–0.882 | −2.584 | 0.010 |
| Zai49 | 2010 | Canada | Caucasian | DSM-IV | 160 | 46 | 34 | 50 | 30 | 0.812 | 0.431–1.530 | −0.645 | 0.519 |
| Total | 1704 | 502 | 350 | 530 | 322 | 0.869 | 0.713–1.059 | −1.395 | 0.163 | ||||
Fig. 4Forest plot of the association between DRD3 Ser9Gly and schizophrenia for HRR studies. a: the statistical significance and Ser9 as a protective factor; b: the statistical significance and Ser9 as a risk factor
Subgroup analysis of the association between DRD3 Ser9Gly and schizophrenia in HRR studies
| Author | Year | Location | Ethnicity | Diagnostic criteria | Transmitted | Untransmitted | OR | 95% CI | Z-value | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ser9 | Gly9 | Ser9 | Gly9 | |||||||||
| Ambrosio42 | 2004 | Portugal | Caucasian | DSM-IV | 122 | 58 | 126 | 54 | 0.901 | 0.577–1.409 | −0.455 | 0.649 |
| Zai49 | 2010 | Canada | Caucasian | DSM-IV | 46 | 34 | 50 | 30 | 0.812 | 0.431–1.530 | −0.645 | 0.519 |
| Total | 168 | 92 | 176 | 84 | 0.871 | 0.604–1.254 | −0.744 | 0.457 | ||||
Fig. 5Funnel plot of study precision by log odds ratio for HRR studies